DRMTY (Dr. Martens) ROCE %: 16.11% (As of Mar. 2026)


DRMTY Dr. Martens PLC DRMTY
73 GF Score
Price $1.83
GF Value $1.89
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Dr. Martens ROCE %?

Dr. Martens DRMTY 73 ROCE % is 16.11% as of Mar. 2026. GuruFocus rates DRMTY with a GF Score™ of 73/100 and a GF Value™ of $1.89 (Fairly Valued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dr. Martens's annualized ROCE % for the quarter that ended in Mar. 2026 was 16.11%.

Dr. Martens  (OTCPK:DRMTY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dr. Martens ROCE % Related Terms

Dr. Martens ROCE % Historical Data

* Premium members only.

The historical data trend for Dr. Martens's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr. Martens ROCE % Chart

Dr. Martens Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only 37.11 22.22 15.60 5.01 8.32

Dr. Martens Semi-Annual Data
Mar18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.59 -3.72 13.97 0.72 16.11
DRMTY
73GF Score
Dr. Martens PLC DRMTY
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dr. Martens ROCE % Calculation

Dr. Martens's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=79.067/( ( (1149.612 - 204.91) + (1169.733 - 213.2) )/ 2 )
=79.067/( (944.702+956.533)/ 2 )
=79.067/950.6175
=8.32 %

Dr. Martens's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=151.466/( ( (1169.459 - 245.946) + (1169.733 - 213.2) )/ 2 )
=151.466/( ( 923.513 + 956.533 )/ 2 )
=151.466/940.023
=16.11 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 16.11% mean?
Dr. Martens (DRMTY) has a ROCE % of 16.11% as of Mar. 2026.
Is Dr. Martens' ROCE % too high?
Dr. Martens' current ROCE % is 16.11%. The Manufacturing - Apparel & Accessories industry median ROCE % is 6.21. Dr. Martens' value of 16.11% is 159.4% above this industry median. Overall, Dr. Martens has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' ROCE % compare to NKE and DECK?
Dr. Martens' ROCE % of 16.11% can be compared against companies in the Manufacturing - Apparel & Accessories industry. The industry median ROCE % is 6.21. Dr. Martens' value of 16.11% is 159.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Manufacturing - Apparel & Accessories company?
The median ROCE % among Manufacturing - Apparel & Accessories companies is 6.21, based on 1,041 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current ROCE % of 16.11% is 159.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Manufacturing - Apparel & Accessories industry, the median ROCE % is 6.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current ROCE % is 16.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DRMTY) is currently considered Fairly Valued. The stock's GF Value™ is $1.89, compared to a current price of $1.83 — trading 3.2% below its estimated fair value. The current ROCE % is 16.11% and 159.4% above the Manufacturing - Apparel & Accessories industry median of 6.21. Dr. Martens' overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Dr. Martens (DRMTY), the current ROCE % is 16.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dr. Martens (DRMTY) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued. The current stock price of $1.83 is trading 3.2% below its estimated GF Value™ of $1.89. GuruFocus considers Dr. Martens to be Fairly Valued.

Key valuation signals for DRMTY:

  • ROCE %: 16.11%
  • GF Value™: $1.89 vs. price of $1.83 (3.2% below fair value)
  • GF Score™: 73/100 with 3 warning signs
  • Industry Position: 159.4% above the Manufacturing - Apparel & Accessories median

No single metric tells the full story. See the DRMTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Martens Business Description

Address 28 Jamestown Road, Camden, London, GBR, NW1 7BY
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
73GF Score

Get the complete analysis for DRMTY

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.83
Price
$1.89
GF Value